Literature DB >> 9486590

Risk factors for primary central nervous system lymphoma: a case-control study.

D Schiff1, V J Suman, P Yang, W A Rocca, B P O'Neill.   

Abstract

BACKGROUND: The incidence of primary central nervous system lymphoma (PCNSL) has increased over time in both immunocompetent and immunodeficient individuals. The reasons for the increase among immunocompetent patients are unclear.
METHODS: The authors conducted a case-control study of PCNSL at the Mayo Clinic based on cases from local community and referral practices. Cases were all PCNSL patients without immunodeficiency diagnosed between 1975 and 1994 (n = 109). Two groups of controls were selected from the same referral practice, namely, patients with other cancer (cancer controls; n = 101), and patients with a different neurologic disease (neurologic controls; n = 109) seen at our institution during the same time period.
RESULTS: PCNSL was significantly associated with lower education when cases were compared with cancer controls but only suggestively when cases were compared with neurologic controls. PCNSL cases were less likely to have had a history of tonsillectomy or oral contraceptive use compared with both control groups. The findings regarding autoimmune disorders and cardiovascular diseases were inconsistent for the two control groups. Neither farming nor prior personal or family history of cancer appeared to be risk factors for PCNSL.
CONCLUSIONS: The findings of this study warrant further investigation of tonsillectomy and oral contraceptives as possible factors for PCNSL.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9486590

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  5 in total

1.  Racial differences in primary central nervous system lymphoma incidence and survival rates.

Authors:  Jose S Pulido; Robert A Vierkant; Janet E Olson; Lauren Abrey; David Schiff; Brian Patrick O'Neill
Journal:  Neuro Oncol       Date:  2009-03-09       Impact factor: 12.300

2.  Postmenopausal hormone therapy and non-Hodgkin lymphoma: a pooled analysis of InterLymph case-control studies.

Authors:  E V Kane; L Bernstein; P M Bracci; J R Cerhan; L Costas; L Dal Maso; E A Holly; C La Vecchia; K Matsuo; S Sanjose; J J Spinelli; S S Wang; Y Zhang; T Zheng; E Roman; A Kricker
Journal:  Ann Oncol       Date:  2012-09-11       Impact factor: 32.976

3.  Medical history, lifestyle, family history, and occupational risk factors for diffuse large B-cell lymphoma: the InterLymph Non-Hodgkin Lymphoma Subtypes Project.

Authors:  James R Cerhan; Anne Kricker; Ora Paltiel; Christopher R Flowers; Sophia S Wang; Alain Monnereau; Aaron Blair; Luigino Dal Maso; Eleanor V Kane; Alexandra Nieters; James M Foran; Lucia Miligi; Jacqueline Clavel; Leslie Bernstein; Nathaniel Rothman; Susan L Slager; Joshua N Sampson; Lindsay M Morton; Christine F Skibola
Journal:  J Natl Cancer Inst Monogr       Date:  2014-08

4.  Non-Hodgkin lymphoma in women: reproductive factors and exogenous hormone use.

Authors:  Jennifer S Lee; Paige M Bracci; Elizabeth A Holly
Journal:  Am J Epidemiol       Date:  2008-06-10       Impact factor: 4.897

5.  Parity, Age at First Birth, and Risk of Death from Non-Hodgkin's Lymphoma: A Population-Based Cohort Study in Taiwan.

Authors:  Brian K Chen; Chun-Yuh Yang
Journal:  Int J Environ Res Public Health       Date:  2015-08-05       Impact factor: 3.390

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.